Transthyretin (TTR) Recombinant Proteins are proteins produced using recombinant DNA technology that mimic or represent the naturally occurring transthyretin protein. Transthyretin is a plasma protein primarily responsible for transporting thyroid hormones and retinol-binding protein in the bloodstream.

  • Gene Cloning and Expression:
    • Gene Selection: The gene encoding human transthyretin (TTR) is identified and isolated from a cDNA library or genomic DNA.
    • Vector Construction: The TTR gene is inserted into an expression vector that includes necessary regulatory elements (e.g., promoter, ribosome-binding site) to drive protein expression in a host cell.
    • Host Cells: The recombinant vector is introduced into host cells (such as E. coli, yeast, insect cells, or mammalian cells) through transformation or transfection.
  • Protein Expression:
    • Induction Conditions: The host cells are cultured under conditions that promote the expression of the recombinant TTR protein. This often involves optimizing temperature, nutrient composition, and inducers.
    • Protein Production: The TTR protein is synthesized and accumulates within the host cells or is secreted into the culture medium, depending on the expression system used.
  • Protein Purification:
    • Cell Harvesting: Cells or culture supernatants are collected, and the recombinant protein is extracted.
    • Purification Techniques: The TTR protein is purified using methods such as affinity chromatography, ion-exchange chromatography, and size-exclusion chromatography. Tags included in the vector (e.g., His-tag) can facilitate purification.
    • Refolding (if necessary): If the protein is expressed in an insoluble form (inclusion bodies), it may need to be refolded to achieve its functional conformation.
  • Characterization and Validation:
    • SDS-PAGE and Western Blotting: Used to confirm the size and identity of the recombinant TTR protein.
    • Mass Spectrometry: Provides detailed information on the protein's structure and any post-translational modifications.
    • Functional Assays: To evaluate the biological activity of the recombinant TTR, such as its ability to bind thyroid hormones or retinol-binding protein.
  • Applications:
    • Research: Recombinant TTR proteins are used to study TTR's role in physiological processes, such as hormone transport, and its involvement in diseases like amyloidosis.
    • Diagnostics: These proteins can be used in assays to detect TTR levels or mutations associated with genetic disorders.
    • Therapeutics: Recombinant TTR may be used as a therapeutic agent or as a basis for developing therapies for TTR-related diseases.

Transthyretin Recombinant Proteins play a critical role in understanding TTR-related functions and disorders, and they are valuable tools in both research and clinical applications.

704.50 704.5 USD
631.00 631.0 USD
605.50 605.5 USD
643.00 643.0 USD
518.50 518.5 USD
518.50 518.5 USD
605.50 605.5 USD
518.50 518.5 USD
1,009.00 1009.0 USD
631.00 631.0 USD
398.50 398.5 USD
518.50 518.5 USD